Aptamer- and Lauric Acid-Modified Au Nanocrystals for Targeted Doxorubicin Delivery and Combined Phototherapy, Chemotherapy, and Immunotherapy
Source abstract
Abstract
A bispecific thermosensitive system was created to deliver drugs and aid T cells in identifying cancer cells for enhancing the tumor-killing effect. Among various nanocarriers, gold nanocages (AuNCs) were selected as the photothermal agents for photothermal therapy (PTT) due to their distinctive hollow and void structures, which make them ideal carriers throughout the therapy. To achieve controlled drug release under near-infrared radiation, lauric acid (LA) was chosen as the “gatekeeper”, responding to a temperature stimulus. Bispecific aptamers with surface modifications were utilized to increase the intracellular drug content while triggering the immune system to eliminate the cancer cells. The homologous targeting ability of AuNCs/LA/ doxorubicin (DOX)/Apt resulted in a high tumor site aggregation. PTT-induced in situ tumor heat elimination and increased tumor cell immunogenicity upon exposure to laser irradiation. Consequently, the smart nano platform not only destroyed the tumor cells through PTT and chemotherapy but also formed a T cell–cancer cell complex at the tumor site, causing the immune cells to precisely identify the tumor and achieve in situ activation of the immune response at the tumor site. The proposed strategy was a classic “cocktail therapy”.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China
Funding
Qilu University of Technology · Taishan Scholar Project of Shandong Province · National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · University Institute Innovation Team of Jinan
References (54)
Show source-provided references
1. 10.1021/acsami.0c1902710.1021/acsami.0c19027 ↗
2. 10.1016/j.phrs.2020.10493210.1016/j.phrs.2020.104932 ↗
3. 10.1016/j.celrep.2022.11195510.1016/j.celrep.2022.111955 ↗
4. 10.1002/smll.20220197110.1002/smll.202201971 ↗
5. 10.1016/j.jconrel.2020.04.02910.1016/j.jconrel.2020.04.029 ↗
6. 10.1002/smll.20180175410.1002/smll.201801754 ↗
7. 10.3390/pharmaceutics1411227910.3390/pharmaceutics14112279 ↗
8. 10.1016/j.biomaterials.2016.08.02210.1016/j.biomaterials.2016.08.022 ↗
9. 10.1007/s00216-019-01966-010.1007/s00216-019-01966-0 ↗
10. 10.1016/j.cej.2023.14215910.1016/j.cej.2023.142159 ↗
11. 10.1186/s12951-019-0513-z10.1186/s12951-019-0513-z ↗
12. 10.1002/adfm.20200973310.1002/adfm.202009733 ↗
13. 10.7150/thno.8184510.7150/thno.81845 ↗
14. 10.1016/j.msec.2019.10989110.1016/j.msec.2019.109891 ↗
15. 10.1016/j.jconrel.2020.08.05510.1016/j.jconrel.2020.08.055 ↗
16. 10.1002/adhm.20200180610.1002/adhm.202001806 ↗
17. 10.1016/j.matdes.2022.11039110.1016/j.matdes.2022.110391 ↗
18. 10.2147/IJN.S13108910.2147/IJN.S131089 ↗
19. 10.1002/smll.20190030910.1002/smll.201900309 ↗
20. 10.1186/s12951-021-01202-x10.1186/s12951-021-01202-x ↗
21. 10.1002/adhm.20190173910.1002/adhm.201901739 ↗
22. 10.1016/j.ymthe.2022.03.00310.1016/j.ymthe.2022.03.003 ↗
23. 10.1039/C8TB00224J10.1039/C8TB00224J ↗
24. 10.1016/j.talanta.2017.08.08710.1016/j.talanta.2017.08.087 ↗
25. 10.1093/nsr/nwac00610.1093/nsr/nwac006 ↗
26. 10.3389/fchem.2022.94618310.3389/fchem.2022.946183 ↗
27. 10.7150/thno.2619510.7150/thno.26195 ↗
28. 10.1016/j.actbio.2019.06.01410.1016/j.actbio.2019.06.014 ↗
29. 10.3389/fchem.2023.116758610.3389/fchem.2023.1167586 ↗
30. 10.1186/s13045-020-00939-610.1186/s13045-020-00939-6 ↗
31. 10.1016/j.it.2016.10.00310.1016/j.it.2016.10.003 ↗
32. 10.1038/s41418-020-00658-y10.1038/s41418-020-00658-y ↗
33. 10.1016/j.biomaterials.2022.12193610.1016/j.biomaterials.2022.121936 ↗
34. 10.1021/acsnano.2c1140310.1021/acsnano.2c11403 ↗
35. 10.1002/adma.20220759310.1002/adma.202207593 ↗
36. 10.1038/s41467-020-19970-910.1038/s41467-020-19970-9 ↗
37. 10.1002/smtd.20230020410.1002/smtd.202300204 ↗
38. 10.1021/acsnano.2c1260010.1021/acsnano.2c12600 ↗
39. 10.1016/j.biomaterials.2019.11946910.1016/j.biomaterials.2019.119469 ↗
40. 10.1126/sciadv.aba077610.1126/sciadv.aba0776 ↗
41. 10.1126/sciadv.abc782810.1126/sciadv.abc7828 ↗
42. 10.1021/nn800370j10.1021/nn800370j ↗
43. 10.1016/j.actbio.2017.06.02610.1016/j.actbio.2017.06.026 ↗
44. 10.1016/j.biomaterials.2019.11932710.1016/j.biomaterials.2019.119327 ↗
45. 10.1021/ja200894u10.1021/ja200894u ↗
46. 10.1002/adhm.20180111310.1002/adhm.201801113 ↗
47. 10.1016/j.biomaterials.2018.03.05810.1016/j.biomaterials.2018.03.058 ↗
48. 10.1021/acsami.1c0002210.1021/acsami.1c00022 ↗
49. 10.1016/j.actbio.2016.04.02410.1016/j.actbio.2016.04.024 ↗
50. 10.1016/j.biopha.2020.11066010.1016/j.biopha.2020.110660 ↗
51. 10.1080/08923973.2021.202317310.1080/08923973.2021.2023173 ↗
52. 10.1016/j.cytogfr.2016.07.00510.1016/j.cytogfr.2016.07.005 ↗
53. 10.1016/j.cytogfr.2018.04.00110.1016/j.cytogfr.2018.04.001 ↗
54. 10.1016/j.actbio.2021.07.05110.1016/j.actbio.2021.07.051 ↗